Page 28 - P4403.59-V51_Numark Magazine May 24 DIGITAL

Regular price adjustments

DHSC gather market information from the supply chain every quarter, using
their legislative powers. This information tells them how much of every product
has been sold into the market and at what price.
DHSC use the data they gathered from manufacturers specifically to
calculate an average manufacturers’ selling price into the market for every
product. This is weighted by how much each manufacturer sold and at what
price. This price is compared to the same calculation from the previous quarter,
to determine the change in the average market price (delta) for every product.

Even when the margin survey highlights that we
need to increase the tariff, market insight from
manufacturers might offset or reverse this rise.

DHSC then need to work out what the change in Target NIC should be, given
the delta for any given product. To do this, DHSC multiply the delta by the
volume of that product dispensed by pharmacies in the latest 3 month’s
available data.
This process is conducted for every Cat M product. The sum of all changes for
every product then tells the DHSC what the total change in Target NIC due to
underlying market movements needs to be, when setting the Cat M price list
for the upcoming quarter.

Average reimbursement price (inc concession pricing)*

Apixaban added
3.40 £3.37 £3.38
£3.35
3.30 £3.26
£3.24
3.20 Apixaban 32p
3.10 £3.09 £3.06
£3.02 £3.04 £3.02
3.00 £2.97 £2.98
2.90 Apixaban 10p £2.86
2.80 Apixaban 2p
2.70
2.60
2.50
2.40
2.30
2.20
2.10
2.00
Jan 23 Feb 23 Mar 23 Apr 23 May 23 Jun 23 Jul 23 Aug 23 Sep 23 Oct 23 Nov 23 Dec 23 Jan 24

28